EM-T3Expert Opinion on Drug Safety2026-02-10第 25 卷第 8 期，1415-1429
Rare irAEs associated with immune checkpoint inhibitor therapy
- Jarrett RongThe University of Texas Health Science Center at Houston
- Faraz I. JafriThe University of Texas Health Science Center at Houston
- Sean NgoThe University of Texas Health Science Center at Houston
- Anirudha ChatterjeeThe University of Texas Medical Branch at Galveston
- Maria Julia Moura Nascimento SantosThe University of Texas MD Anderson Cancer Center
- Devin M. GarzaThe University of Texas Medical Branch at Galveston
- Hamza SalimThe University of Texas Medical Branch at Galveston
- Raakhi MenonThe University of Texas Medical Branch at Galveston
- Rachel E. MortanThe University of Texas Health Science Center at Houston
- Andres Caleb Urias RiveraBaylor College of Medicine
- Hao Chi ZhangThe University of Texas MD Anderson Cancer Center
- Anisha B. PatelThe University of Texas MD Anderson Cancer Center
- Cristhiam Rojas HernandezThe University of Texas MD Anderson Cancer Center
- Yuanteng Jeff LiThe University of Texas MD Anderson Cancer Center
- Ajay SheshadriThe University of Texas MD Anderson Cancer Center
- Ashley AaroeThe University of Texas MD Anderson Cancer Center
- Afreen Idris ShariffDuke University
- Bryan SchneiderUniversity of Michigan
- Anusha ThomasThe University of Texas MD Anderson Cancer Center
- Yinghong WangThe University of Texas MD Anderson Cancer Center